Multimodal Imaging Evaluation and Prognostic Analysis of Cardiac Allograft Vasculopathy in Heart Transplantation

Launched by XIE MINGXING · Jul 16, 2021

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to use advanced imaging technology to help doctors better understand and diagnose a condition called cardiac allograft vasculopathy in people who have received heart transplants. Cardiac allograft vasculopathy is a serious condition that can affect the health of a transplanted heart over time. The goal of the study is to combine different imaging techniques to create a model that can predict potential health issues, helping doctors find the best and least invasive ways to monitor their patients.

To be part of this trial, participants need to have had a heart transplant after January 1, 2015, and be between the ages of 65 and 74 or 29 and 219. Unfortunately, those under 18, patients who died shortly after surgery, or those who had combined heart-lung or heart-kidney transplants will not be eligible. While the trial is not yet recruiting participants, interested individuals can expect to undergo various imaging tests as part of the study. This research could ultimately lead to better long-term care for heart transplant patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • • Heart transplantation after January 1st, 2015.
• Exclusion Criteria:
• • •Age \< 18 years at the time of transplantation; Died within 48 h; Heart-lung transplantation; Heart/kidney transplantation; Re-transplanted within 7 days after transplantation.